Fundraising FoxWalnut Venture Associates — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
AltrixBioaltrixbio.comApr 2025
AltrixBio develops AJN003, a once-daily oral therapy that forms a temporary, non-systemic coating on the stomach and upper gastrointestinal tract to alter nutrient sensing and trigger metabolic and hormonal responses.
BiotechDigital HealthHealthtechLongevityWilmington, US
Ali Tavakkoli(Co-founder)Nancy Briefs(Executive Chair of the Board & Founder)inJeff Karp(Co-founder)David Passin
BoardJohn Brooks(Director)
Co-investorsSand Hill AngelsService Provider CapitalTaihill Venturexfactor ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.